Résumé Depuis les premières recommandations de 2020 concernant le cancer de
l'endomètre métastatique et/ou en rechute, de nouvelles options de traitements ont montré …

Oncologists and pathologists alike have recognized that the broad histologic categories,
especially for ovarian and endometrial carcinomas, do not reliably segregate groups with …

Endometrial cancer (EC) represents the most prevalent cancer of the female genital tract
worldwide. Although EC has an overall good prognosis compared to other gynecological …

Résumé Le cancer de l'endomètre est fréquent chez la femme âgée et souvent associé à
des comorbidités. Sa prise en charge en cas de situation métastatique et/ou de rechute …

Endometrial cancer is the fourth most common cancer in women and the most common
gynaecological malignancy in the developed world. No new systemic treatments for …

Objective: To develop a novel Endometrial Cancer Patient-Derived-Explant (EC-PDE)
preclinical model system that is capable of detecting patient-specific drug-responses to …

Endometrial cancer (EC) is a complex disease with various subtypes. Although it is
considered a treatable disease due to early diagnosis and symptoms, the advanced stage …

Docteur en Pharmacie Page 1 Année: 2023 Thèse N:038 LA THERAPIE CIBLEE EN
ONCOLOGIE : CANCER DU SEIN THESE Présentée et soutenue publiquement le : / /2023 …

Endometrial cancer (EC) is the fourth most common female cancer in Serbia, with a peak
incidence between 60 and 70 years of age. It is the most common gynecological disease in …

The major stepping stone laid towards the identification of high-risk endometrial cancers
was made by the Cancer Genome Atlas in 2013 when the four distinct molecular subtypes …